Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Appointed director
|
|
Myrexis, Inc. (MYRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/10/2010 |
8-K
| Acquisition/merger/asset purchase announced |
| 12/18/2009 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger, by and among Myriad Pharmaceuticals, Inc., MPI Merger Sub, Inc., Javelin Pharmaceuticals, Inc., and the Stockholder Representative",
"Form of Escrow Agreement by and among Myriad Pharmaceuticals, Inc., the Escrow Agent, and the Stockholder Representative, to be entered into at or prior to consummation of the Merger",
"Form of Javelin Stockholder Voting Agreement and a schedule of signatories thereto",
"Form of MPI Stockholder Voting Agreement and a schedule of signatories thereto",
"Loan and Security Agreement, by and among Myriad Pharmaceuticals, Inc., Javelin Pharmaceuticals, Inc., and Innovative Drug Delivery Systems, Inc",
"Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals - Creates pipeline with potential near-term product launch of Dyloject™ and portfolio of early-, mid- and late-stage drug candidates in cancer, HIV and pain - -Joint Conference Call Scheduled for 9:00 AM ET Friday, December 18, 2009 -" |
|
|
|